Key Takeaway
Systematic review of 32 preclinical studies finds BPC-157 consistently accelerates healing of tendons, ligaments, muscles, and bones in orthopaedic sports medicine models.
Summary
This systematic review evaluated the emerging use of BPC-157 in orthopaedic sports medicine by analyzing 32 preclinical studies. The review assessed BPC-157's effects across multiple musculoskeletal tissue types including tendons, ligaments, muscles, and bones.
Across the included studies, BPC-157 demonstrated consistent benefits for tissue healing, including accelerated tendon-to-bone integration, improved ligament repair, enhanced muscle regeneration after injury, and promotion of bone fracture healing. The peptide appears to work through multiple pathways including upregulation of growth factors, promotion of angiogenesis, and modulation of nitric oxide signaling.
While the preclinical evidence is encouraging, the authors note that all included studies were animal models. The review highlights a significant gap in human clinical trial data and calls for well-designed randomized controlled trials to validate these findings in human patients before BPC-157 can be recommended for clinical orthopaedic use.
Figures
Figure 1